Patent Application
Utility
App. No. 16/529,323
· Confirmation No. 2940
ZERO-ORDER MODIFIED RELEASE SOLID DOSAGE FORMS
Applicant:
SpecGX LLC
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2020-03-19 | ABN |
Abandonment | 2 | View | |
| 2019-11-29 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2019-09-09 | CTNF |
Non-Final Rejection | 7 | View | |
| 2019-09-09 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2019-09-09 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2019-08-19 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2019-08-19 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-08-19 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2019-08-01 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2019-08-01 | PA.. |
Power of Attorney | 1 | View | |
| 2019-08-01 | ADS |
Application Data Sheet | 8 | View | |
| 2019-08-01 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-08-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-08-01 | SPEC |
Specification | 26 | View | |
| 2019-08-01 | CLM |
Claims | 5 | View | |
| 2019-08-01 | ABST |
Abstract | 1 | View | |
| 2019-08-01 | DRW.NONBW |
Drawings-other than black and white line drawings | 19 | View | |
| 2019-08-01 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
424/468
A61K9/209
A61K9/2886
A61K31/4458
Prosecution
- Examiner
- AHMED, HASAN SYED
- Art Unit
- 1615
- Customer No.
- 24289
- Docket No.
- H-MP-00047 WO/US CON.1
- Confirmation No.
- 2940
Publication
- Pub. No.
- US20190358164A1
- Pub. Date
- 2019-11-28
Parent
is a Continuation of
→
App. 12/299,944
Filed 2008-11-07
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/US2007/011186
Filed 2007-05-09
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 60/798,889
Filed 2006-05-09
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 60/856,226
Filed 2006-11-01
· Provisional Application Expired
MALLINCKRODT INTERNATIONAL FINANCE S.A.,
MALLINCKRODT CB LLC,
MALLINCKRODT FINANCE GMBH,
MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.),
MALLINCKRODT CARRIBEAN, INC.,
MALLINCKRODT US POOL LLC,
MNK 2011 LLC (F/K/A MALLINCKRODT INC.),
LUDLOW LLC (F/K/A LUDLOW CORPORATION),
CNS THERAPEUTICS, INC.,
MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.),
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
LAFAYETTE PHARMACEUTICALS LLC,
LIEBEL-FLARSHEIM COMPANY LLC,
MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.),
MALLINCKRODT VETERINARY, INC.,
MALLINCKRODT US HOLDINGS LLC,
IMC EXPLORATION COMPANY,
MEH, INC.,
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED),
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED),
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC (F/K/A VTESSE INC.),
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.),
INFACARE PHARMACEUTICAL CORPORATION,
ST SHARED SERVICES LLC,
THERAKOS, INC.,
IKARIA THERAPEUTICS LLC,
INO THERAPEUTICS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 051231, FRAME 0961
Recorded 2023-11-16
OCERA THERAPEUTICS, INC.,
MALLINCKRODT LLC,
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED),
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED),
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY),
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE LLC (F/K/A VTESSE INC.)
RELEASE OF SECURITY INTEREST
Recorded 2022-06-17
from
MALLINCKRODT ARD IP LIMITED,
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE INC.
SECURITY INTEREST
Recorded 2019-12-10
from
MALLINCKRODT ARD IP LIMITED,
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING D.A.C.,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
VTESSE INC.
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY
Recorded 2019-12-09
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/529,323
- Filed
- 2019-08-01
- Pub. No.
- US20190358164A1
- Examiner
- AHMED, HASAN SYED
- Art Unit
- 1615
External Links